{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:57:43Z","timestamp":1791575863194,"version":"4.3.4"},"reference-count":138,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:p>Today's world population is currently faced with a new type\u00a0of non-transmissible pandemic: obesity. This lifestyle-related condition is driving the emergence of the diabetes pandemic through the development of low-level chronic inflammation. In recent years, a novel class of non-coding RNA, microRNA (miRNA), have emerged as being important regulators of numerous biological functions. Among these functions are basic maintenance of cell signalling and tissue architecture. Disruption of miRNA levels can contribute not only to the development of the chronic inflammation observed in obese diabetics, but also the development of both pancreatic \u03b2-cell dysfunction and loss, along with insulin resistance in metabolic tissues. These primary events set the scene for dysfunction of other tissues, including the retina, kidney, peripheral nerves, heart and the vasculature as a whole. Here, miRNAs again play a deterministic role in the development of a range of diseases collectively termed diabetic complications. Disturbances in miRNA levels appear to be reflected in the serum of patients and this may prove to be diagnostic in patients prior to clinical manifestation of disease, thus improving management of diabetes and its associated complications. Not only are miRNAs displaying promise as an early biomarker for disease, but a number of these miRNAs are displaying therapeutic potential with several in pre-clinical development. The present review aims to highlight our current understanding of miRNAs and their interaction with inflammatory signalling in the development and progression of diabetes and its complications. Utilization of miRNAs as biomarkers and therapeutic targets will also be considered.<\/jats:p>","DOI":"10.1042\/cs20130079","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T09:19:56Z","timestamp":1379063996000},"page":"95-110","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["microRNA in the development of diabetic complications"],"prefix":"10.1042","volume":"126","author":[{"given":"Aaron D.","family":"McClelland","sequence":"first","affiliation":[{"name":"JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Kantharidis","sequence":"additional","affiliation":[{"name":"JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"key":"2021113010322875500_B1","article-title":"Epidemics and Pandemics: Their Impacts on Human History","author":"Hays","year":"2005","journal-title":"ABC-CLIO, Santa Barbara"},{"key":"2021113010322875500_B2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"2021113010322875500_B3","volume-title":"OECD Health Data 2012","author":"Organisation for Economic Co-operation and Development","year":"2012"},{"key":"2021113010322875500_B4","article-title":"World Health Statistics","volume-title":"Report 2012","author":"World Health Organization","year":"2012"},{"key":"2021113010322875500_B5","volume-title":"Global status report on noncommunicable diseases 2010","author":"World Health Organization","year":"2011"},{"key":"2021113010322875500_B6","doi-asserted-by":"crossref","first-page":"a007724","DOI":"10.1101\/cshperspect.a007724","article-title":"Connecting Type\u00a01 and Type\u00a02 diabetes through innate immunity","volume":"2","author":"Odegaard","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"2021113010322875500_B7","first-page":"3","article-title":"The lean patient with type\u00a02 diabetes: characteristics and therapy challenge","volume":"153","author":"Brunetti","year":"2007","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"2021113010322875500_B8","doi-asserted-by":"crossref","first-page":"e17386","DOI":"10.1371\/journal.pone.0017386","article-title":"Adipose tissue deficiency and chronic inflammation in diabetic goto-kakizaki rats","volume":"6","author":"Xue","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113010322875500_B9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11892-007-0038-y","article-title":"Inflammatory mechanisms of diabetic complications","volume":"7","author":"Williams","year":"2007","journal-title":"Curr. Diabetes Rep."},{"key":"2021113010322875500_B10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"2021113010322875500_B11","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.mt.6300311","article-title":"MicroRNAs in disease and potential therapeutic applications","volume":"15","author":"Soifer","year":"2007","journal-title":"Mol. Ther."},{"key":"2021113010322875500_B12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrm2347","article-title":"Small non-coding RNAs in animal development","volume":"9","author":"Stefani","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021113010322875500_B13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(81)90501-8","article-title":"Mutations that lead to reiterations in the cell lineages of C. elegans","volume":"24","author":"Chalfie","year":"1981","journal-title":"Cell"},{"key":"2021113010322875500_B14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"2021113010322875500_B15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"2021113010322875500_B16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Lagos-Quintana","year":"2001","journal-title":"Science"},{"key":"2021113010322875500_B17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"2021113010322875500_B18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","article-title":"Genomic organization of microRNAs","volume":"222","author":"Olena","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"2021113010322875500_B19","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1093\/nar\/gkm641","article-title":"Tissue-dependent paired expression of miRNAs","volume":"35","author":"Ro","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"2021113010322875500_B20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1101\/gr.139758.112","article-title":"Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation","volume":"23","author":"Hausser","year":"2013","journal-title":"Genome Res."},{"key":"2021113010322875500_B21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gr.089367.108","article-title":"New class of microRNA targets containing simultaneous 5\u2032-UTR and 3\u2032-UTR interaction sites","volume":"19","author":"Lee","year":"2009","journal-title":"Genome Res."},{"key":"2021113010322875500_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2007.12.010","article-title":"Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs","volume":"29","author":"Wu","year":"2008","journal-title":"Mol. Cell"},{"key":"2021113010322875500_B23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/msb.2011.23","article-title":"Characterizing the role of miRNAs within gene regulatory networks using integrative genomics techniques","volume":"7","author":"Su","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"2021113010322875500_B24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db11-0082","article-title":"Diabetes complications: the microRNA perspective","volume":"60","author":"Kantharidis","year":"2011","journal-title":"Diabetes"},{"key":"2021113010322875500_B25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1902\/jop.2008.080246","article-title":"The role of inflammatory cytokines in diabetes and its complications","volume":"79","author":"King","year":"2008","journal-title":"J. Periodontol."},{"key":"2021113010322875500_B26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"2021113010322875500_B27","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.2337\/diabetes.50.2007.S169","article-title":"Decreased insulin secretion in type\u00a02 diabetes: a problem of cellular mass or function?","volume":"50","author":"Clark","year":"2001","journal-title":"Diabetes"},{"key":"2021113010322875500_B28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.53.2.426","article-title":"Insulin secretion in type\u00a01 diabetes","volume":"53","author":"Steele","year":"2004","journal-title":"Diabetes"},{"key":"2021113010322875500_B29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1101\/gad.1550907","article-title":"Mechanisms of obesity-associated insulin resistance: many choices on the menu","volume":"21","author":"Qatanani","year":"2007","journal-title":"Genes Dev."},{"key":"2021113010322875500_B30","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2337\/diabetes.54.suppl_2.S25","article-title":"Natural history of Type\u00a01 diabetes","volume":"54","author":"Achenbach","year":"2005","journal-title":"Diabetes"},{"key":"2021113010322875500_B31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"key":"2021113010322875500_B32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2009.10.012","article-title":"microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type\u00a01 diabetic patients","volume":"260","author":"Hezova","year":"2010","journal-title":"Cell. Immunol."},{"key":"2021113010322875500_B33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2007.03.008","article-title":"miR-181a is an intrinsic modulator of T cell sensitivity and selection","volume":"129","author":"Li","year":"2007","journal-title":"Cell"},{"key":"2021113010322875500_B34","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s00125-012-2539-8","article-title":"Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity","volume":"55","author":"Zhou","year":"2012","journal-title":"Diabetologia"},{"key":"2021113010322875500_B35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"key":"2021113010322875500_B36","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.2337\/db07-1614","article-title":"miR-375 targets 3\u2032-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic \u03b2-cells","volume":"57","author":"El Ouaamari","year":"2008","journal-title":"Diabetes"},{"key":"2021113010322875500_B37","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1073\/pnas.0810550106","article-title":"miR-375 maintains normal pancreatic \u03b1- and \u03b2-cell mass","volume":"106","author":"Poy","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/eem.12.21","article-title":"miRNAs and diabetes mellitus","volume":"7","author":"Karolina","year":"2012","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"2021113010322875500_B39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1262-3636(08)74601-9","article-title":"Adipose tissue inflammation and liver pathology in human obesity","volume":"34","author":"Tordjman","year":"2008","journal-title":"Diabetes Metab."},{"key":"2021113010322875500_B40","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/db08-1299","article-title":"MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity","volume":"58","author":"Xie","year":"2009","journal-title":"Diabetes"},{"key":"2021113010322875500_B41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/1087057110374991","article-title":"Identification of microRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening","volume":"15","author":"Whittaker","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"2021113010322875500_B42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11154-011-9168-2","article-title":"Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity","volume":"12","author":"Eckardt","year":"2011","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2021113010322875500_B43","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1074\/jbc.M312021200","article-title":"Tumor necrosis factor \u03b1 produces insulin resistance in skeletal muscle by activation of inhibitor \u03baB kinase in a p38 MAPK-dependent manner","volume":"279","author":"de Alvaro","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021113010322875500_B44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","article-title":"Alternative macrophage activation and metabolism","volume":"6","author":"Odegaard","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"2021113010322875500_B45","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.4049\/jimmunol.1102001","article-title":"MicroRNA-125b potentiates macrophage activation","volume":"187","author":"Chaudhuri","year":"2011","journal-title":"J. Immunol."},{"key":"2021113010322875500_B46","doi-asserted-by":"crossref","first-page":"e9022","DOI":"10.1371\/journal.pone.0009022","article-title":"miRNA expression profile of human subcutaneous adipose and during adipocyte differentiation","volume":"5","author":"Ortega","year":"2010","journal-title":"PLoS ONE"},{"key":"2021113010322875500_B47","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/embor.2010.93","article-title":"Regulation of interleukin-1\u03b2 by interferon-\u03b3 is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production","volume":"11","author":"Masters","year":"2010","journal-title":"EMBO Rep."},{"key":"2021113010322875500_B48","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.1200081109","article-title":"MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03ba\u03b2 pathway by targeting the tumor necrosis factor \u03b1-induced protein 3 (TNFAIP3, A20)","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B49","doi-asserted-by":"crossref","first-page":"e22839","DOI":"10.1371\/journal.pone.0022839","article-title":"MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type\u00a02 diabetes mellitus","volume":"6","author":"Karolina","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113010322875500_B50","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/nm.2512","article-title":"miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response","volume":"17","author":"Mateescu","year":"2011","journal-title":"Nat. Med."},{"key":"2021113010322875500_B51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/187153009787582397","article-title":"p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type\u00a02 diabetes mellitus","volume":"9","author":"Liu","year":"2009","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"2021113010322875500_B52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"2021113010322875500_B53","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1167\/iovs.10-6879","article-title":"microRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats","volume":"52","author":"Kovacs","year":"2011","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"2021113010322875500_B54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12265-012-9368-5","article-title":"MicroRNAs and Diabetic Complications","volume":"5","author":"Natarajan","year":"2012","journal-title":"J Cardiovasc. Transl. Res."},{"key":"2021113010322875500_B55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"O\u2019Connell","year":"2010","journal-title":"Immunity"},{"key":"2021113010322875500_B56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.2186","article-title":"MicroRNA-132mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis","volume":"16","author":"Anand","year":"2010","journal-title":"Nat. Med."},{"key":"2021113010322875500_B57","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2337\/db11-0478","article-title":"miR-146a-mediated extracellular matrix protein production in chronic diabetes complications","volume":"60","author":"Feng","year":"2011","journal-title":"Diabetes"},{"key":"2021113010322875500_B58","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/db10-1557","article-title":"MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy","volume":"60","author":"McArthur","year":"2011","journal-title":"Diabetes"},{"key":"2021113010322875500_B59","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.2337\/diabetes.53.11.2931","article-title":"Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy","volume":"53","author":"Nyengaard","year":"2004","journal-title":"Diabetes"},{"key":"2021113010322875500_B60","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1167\/iovs.10-6879","article-title":"microRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats","volume":"21","author":"Kovacs","year":"2011","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"2021113010322875500_B61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexmp.2011.04.016","article-title":"MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors","volume":"91","author":"Bai","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"2021113010322875500_B62","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"2021113010322875500_B63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.2005.036137","article-title":"Diabetic neuropathy","volume":"82","author":"Bansal","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"2021113010322875500_B64","first-page":"004","article-title":"Inflammatory mediators in diabetic neuropathy","volume":"S5","author":"Wright","year":"2011","journal-title":"J. Diabetes Metab."},{"key":"2021113010322875500_B65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajpath.2011.04.021","article-title":"miR-21 and miR-214 are consistently modulated during renal injury in rodent models","volume":"179","author":"Denby","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2021113010322875500_B66","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.21675","article-title":"Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial","volume":"65","author":"Ropper","year":"2009","journal-title":"Ann. Neurol."},{"key":"2021113010322875500_B67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.expneurol.2008.02.011","article-title":"Transforming growth factor-\u03b2 induces cellular injury in experimental diabetic neuropathy","volume":"211","author":"Anjaneyulu","year":"2008","journal-title":"Exp. Neurol."},{"key":"2021113010322875500_B68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.semnephrol.2010.03.007","article-title":"Macrophages and diabetic nephropathy","volume":"30","author":"Tesch","year":"2010","journal-title":"Semin. Nephrol."},{"key":"2021113010322875500_B69","doi-asserted-by":"crossref","first-page":"146154","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in diabetic nephropathy","volume":"2012","author":"Lim","year":"2012","journal-title":"Mediators Inflamm."},{"key":"2021113010322875500_B70","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.2004110970","article-title":"Pathogenetic mechanisms of diabetic nephropathy","volume":"16","author":"Schena","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010322875500_B71","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/db08-0061","article-title":"From fibrosis to sclerosis","volume":"57","author":"Qian","year":"2008","journal-title":"Diabetes"},{"key":"2021113010322875500_B72","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI38019","article-title":"Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease","volume":"119","author":"Acloque","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2021113010322875500_B73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"2021113010322875500_B74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/db10-0892","article-title":"miR-200a prevents renal fibrogenesis through repression of TGF-\u03b22 expression","volume":"60","author":"Wang","year":"2011","journal-title":"Diabetes"},{"key":"2021113010322875500_B75","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0006-291X(03)00885-4","article-title":"Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy","volume":"305","author":"Fujimoto","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010322875500_B76","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.2011010055","article-title":"Suppression of microRNA-29 expression by TGF-\u03b21 promotes collagen expression and renal fibrosis","volume":"23","author":"Wang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010322875500_B77","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/db09-1736","article-title":"E-cadherin expression is regulated by miR-192\/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-\u03b2","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"key":"2021113010322875500_B78","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1073\/pnas.0611192104","article-title":"MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-\u03b2-induced collagen expression via inhibition of E-box repressors","volume":"104","author":"Kato","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B79","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1681\/ASN.2010020134","article-title":"miR-192 mediates TGF-\u03b2\/Smad3-driven renal fibrosis","volume":"21","author":"Chung","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010322875500_B80","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1681\/ASN.2009050530","article-title":"Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy","volume":"21","author":"Krupa","year":"2010","journal-title":"J. Am. Soc. Nephrol"},{"key":"2021113010322875500_B81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ncb1897","article-title":"TGF-\u03b2 activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN","volume":"11","author":"Kato","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"2021113010322875500_B82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.febslet.2009.05.021","article-title":"MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db\/db mice","volume":"583","author":"Zhang","year":"2009","journal-title":"FEBS Lett."},{"key":"2021113010322875500_B83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/mt.2012.251","article-title":"Smad7 suppresses renal fibrosis via altering expression of TGF-\u03b2\/Smad3-regulated microRNAs","volume":"21","author":"Chung","year":"2013","journal-title":"Mol. Ther."},{"key":"2021113010322875500_B84","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","article-title":"Smad3-mediated upregulation of miR-21 promotes renal fibrosis","volume":"22","author":"Zhong","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010322875500_B85","doi-asserted-by":"crossref","first-page":"14339","DOI":"10.1073\/pnas.0912701107","article-title":"Identification of a microRNA signature of renal ischemia reperfusion injury","volume":"107","author":"Godwin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MNH.0b013e32832c9da2","article-title":"MicroRNAs and the kidney: coming of age","volume":"18","author":"Saal","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113010322875500_B87","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1096\/fj.08-112326","article-title":"MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J."},{"key":"2021113010322875500_B88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2021113010322875500_B89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1423-0127-19-79","article-title":"Roles of microRNAs in atherosclerosis and restenosis","volume":"19","author":"Chen","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"2021113010322875500_B90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"2021113010322875500_B91","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4161\/cc.8.5.7753","article-title":"MiR-34, SIRT1 and p53: the feedback loop","volume":"8","author":"Yamakuchi","year":"2009","journal-title":"Cell Cycle"},{"key":"2021113010322875500_B92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu","year":"2011","journal-title":"Atherosclerosis"},{"key":"2021113010322875500_B93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ. Res."},{"key":"2021113010322875500_B94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.febslet.2010.02.063","article-title":"Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation","volume":"584","author":"Tang","year":"2010","journal-title":"FEBS Lett."},{"key":"2021113010322875500_B95","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2310\/JIM.0b013e3181ff46d7","article-title":"MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages","volume":"58","author":"Huang","year":"2010","journal-title":"J. Investig. Med."},{"key":"2021113010322875500_B96","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/HJH.0b013e32833a4922","article-title":"MicroRNA-125a\/b-5p inhibits endothelin-1 expression in vascular endothelial cells","volume":"28","author":"Li","year":"2010","journal-title":"J. Hypertens."},{"key":"2021113010322875500_B97","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cvr\/cvp121","article-title":"MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake and ORP9 expression in oxLDL-stimulated monocyte\/macrophages","volume":"83","author":"Chen","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"2021113010322875500_B98","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.2337\/db10-0208","article-title":"Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db\/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1","volume":"59","author":"Villeneuve","year":"2010","journal-title":"Diabetes"},{"key":"2021113010322875500_B99","doi-asserted-by":"crossref","first-page":"e16979","DOI":"10.1371\/journal.pone.0016979","article-title":"MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells","volume":"6","author":"Sabatel","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113010322875500_B100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2012.01.020","article-title":"The magic and mystery of microRNA-27 in atherosclerosis","volume":"222","author":"Chen","year":"2012","journal-title":"Atherosclerosis"},{"key":"2021113010322875500_B101","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2012","journal-title":"Heart Failure Rev."},{"key":"2021113010322875500_B102","doi-asserted-by":"crossref","first-page":"H1366","DOI":"10.1152\/ajpheart.00111.2012","article-title":"Macrophages modulate cardiac function in lipotoxic cardiomyopathy","volume":"303","author":"Schilling","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010322875500_B103","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12265-010-9169-7","article-title":"MicroRNA-21 in cardiovascular disease","volume":"3","author":"Cheng","year":"2010","journal-title":"J Cardiovasc. Transl. Res."},{"key":"2021113010322875500_B104","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"2021113010322875500_B106","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"2021113010322875500_B107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1258\/ebm.2010.010269","article-title":"microRNAs in hypertrophy and heart failure","volume":"236","author":"Latronico","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"2021113010322875500_B108","first-page":"70","article-title":"Using cytokines to stimulate neoangiogenesis and cardiac regeneration","volume":"69","author":"Maslov","year":"2006","journal-title":"Eksp. Klin. Farmakol."},{"key":"2021113010322875500_B109","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"2021113010322875500_B110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"2021113010322875500_B111","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type\u00a02 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ. Res."},{"key":"2021113010322875500_B112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","article-title":"Significance of serum microRNAs in pre-diabetes and newly diagnosed type\u00a02 diabetes: a clinical study","volume":"48","author":"Kong","year":"2011","journal-title":"Acta Diabetol."},{"key":"2021113010322875500_B113","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"2021113010322875500_B114","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021113010322875500_B115","first-page":"3794","article-title":"Circulating microRNA expression is reduced in chronic kidney disease","volume-title":"Nephrol. Dial. Transplant.","author":"Neal","year":"2011"},{"key":"2021113010322875500_B116","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2011\/304852","article-title":"Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy","volume":"30","author":"Wang","year":"2011","journal-title":"Dis. Markers"},{"key":"2021113010322875500_B117","doi-asserted-by":"crossref","first-page":"e54662","DOI":"10.1371\/journal.pone.0054662","article-title":"Urinary microRNA profiling in the nephropathy of Type\u00a01 diabetes","volume":"8","author":"Argyropoulos","year":"2013","journal-title":"PLoS ONE"},{"key":"2021113010322875500_B118","doi-asserted-by":"crossref","first-page":"H1085","DOI":"10.1152\/ajpheart.00191.2012","article-title":"Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases","volume":"303","author":"Tijsen","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010322875500_B119","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijcard.2012.01.075","article-title":"Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction","volume":"167","author":"Olivieri","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"2021113010322875500_B120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2010.09.029","article-title":"Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans","volume":"412","author":"Li","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"2021113010322875500_B121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00395-010-0123-2","article-title":"MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction","volume":"106","author":"Meder","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"2021113010322875500_B122","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvs007","article-title":"Microparticles: major transport vehicles for distinct microRNAs in circulation","volume":"93","author":"Diehl","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"2021113010322875500_B123","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1093\/nar\/gkr330","article-title":"Experimental strategies for microRNA target identification","volume":"39","author":"Thomson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"2021113010322875500_B124","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1007\/s11095-010-0156-0","article-title":"A direct comparison of anti-microRNA oligonucleotide potency","volume":"27","author":"Lennox","year":"2010","journal-title":"Pharm. Res."},{"key":"2021113010322875500_B125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ki.2011.43","article-title":"A microRNA circuit mediates transforming growth factor-\u03b21 autoregulation in renal glomerular mesangial cells","volume":"80","author":"Kato","year":"2011","journal-title":"Kidney Int."},{"key":"2021113010322875500_B126","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy","volume":"23","author":"Putta","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010322875500_B127","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1073\/pnas.1105254108","article-title":"Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters","volume":"108","author":"Zhou","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B128","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"149","author":"Grueter","year":"2012","journal-title":"Cell"},{"key":"2021113010322875500_B129","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"key":"2021113010322875500_B130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2009","journal-title":"Cell Death Differ."},{"key":"2021113010322875500_B131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/PPO.0b013e318258b5d6","article-title":"The therapeutic potential of microRNAs in cancer","volume":"18","author":"Thorsen","year":"2012","journal-title":"Cancer J."},{"key":"2021113010322875500_B132","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010322875500_B133","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"2021113010322875500_B134","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic delivery of miR-26a inhibits cancer cell proliferation and induces tumor-specific apoptosis","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"2021113010322875500_B135","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/mt.2012.269","article-title":"Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression","volume":"21","author":"Uchino","year":"2013","journal-title":"Mol. Ther."},{"key":"2021113010322875500_B136","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/gt.2011.50","article-title":"MicroRNA therapeutics","volume":"18","author":"Broderick","year":"2011","journal-title":"Gene Ther."},{"key":"2021113010322875500_B137","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"RNA"},{"key":"2021113010322875500_B138","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/126\/2\/95\/444328\/cs1260095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/126\/2\/95\/444328\/cs1260095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:38:04Z","timestamp":1715981884000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/126\/2\/95\/69260\/microRNA-in-the-development-of-diabetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,13]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20130079","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,13]]}}}